Delivery Order SPE2DB20D1051-SPE2DB25FD8XD
Award Date 7/24/25
Potential Completion Date 8/14/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,288.86 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Envarsus XR 1 mg tablets (100-count package), with an ultimate completion date of August 12, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. The product will be delivered to the company's...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order, valued at $1,615.33, is for the supply of the specialty medication Envarsus XR 4 mg tablet 100s. The delivery order has an ultimate completion date of April 8, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as a prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 firm fixed-price delivery order is for the supply of Envarsus XR 4 mg tablets, a medication used in organ transplant patients. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,216.11 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of Envarsus XR 1 mg tablets. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, AmerisourceBergen provides a wide range of pharmaceutical products and medical supplies to support the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The $1,621.48 order is for the supply of the pharmaceutical product Envarsus XR 1 mg Tablet 100s. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceuticals...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,216.11, is for the supply of Envarsus XR 1 MG tablets. This order is placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.95, is for the delivery of Envarsus XR 4 mg tablets over a performance period ending on May 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
- This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The $17,061.84 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor that is registered in the System for Award Management (SAM.gov) through June 2025. The contract has an ultimate completion date of August 17, 2023 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 firm-fixed-price contract is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency (DLA) awarded a $1,099.26 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Envarsus XR 1 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...